Enliven: Immunology and Immunotechniques is an Open access, peer reviewed international journal and it aims to publish different types of articles on emerging developments and supports current and upcoming research in the field of immunology. This journal also allows articles on immunotechniques.
This journal will support the budding scientists, scholars, academicians, researchers, and students by providing Open access platform for publishing their work.
This journal will follow the peer review policies and will bode Open access in having quality research output.
This journal combines the innovative scientific ideas and ways in immunology, immunotechniques and all other related disciplines to have an innovative output.
Enliven: Immunology and Immunotechniques invites articles from authors and we assure authors that articles received will be processed with the best policies and will disseminate the articles to the right field.
Enliven: Immunology and Immunotechniques disseminate the research findings in Cellular and Clinical Immunological aspects such as Cancer immunology, Transplantation immunology, innate immunology, vaccine development, cancer immunotherapy, allergy immunology, immunomodulation, Multiple sclerosis, Systemic lupus erythmatosus, immunology, immunoinformatics, immunogenicity of Biopharmaceuticals, and all other related areas.
Official Media Partners:
On 12 & 13 November 2018, Dublin (Ireland) will host the BioTech Pharma Summit: Immunotherapy 2018 conference. This year’s event will bring together established Pharma & Biotech thought-leaders, top academics and researchers, and a collection of emerging scientists exploring next-generation breakthroughs in the burgeoning area of cancer immunotherapy.
Go through: https://biotechpharmasummit.com/index.php/event/immunotherapy-2018/ for further details
On 06 & 07 December 2018, Boston (USA) will host the BioTech Pharma Summit: Neoantigen 2018 conference. This year’s event will bring together the pioneers supercharging immunotherapy and vaccine development to share key clinical data and insights from sample acquisition, all the way through to vaccine manufacturing and getting a product to market.
Go through: https://biotechpharmasummit.com/index.php/event/neoantigen-2018/ for further details
“25th International Conference on Human Metabolic Health- Diabetes, Obesity & Metabolism" scheduled during March 21-22, 2019, Dubai, UAE with the theme, “Collective impact on human metabolism”.
Human Metabolic Health- Diabetes, Obesity, & Metabolism organizes a scientific gatherings with the heed of bringing together world renowned researchers and scientists to ponder upon the Challenges and solutions faced by the Social Community.
Pulsus Group invites all the participants from all over the world to attend 9th Global Summit on Neuroscience and Neuroimmunology, May 22-23, 2019 in London, UK. Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
The scientific sessions of Neuroscience and Neuroimmunology-2019 will focus on the current research areas includes neuroimmunological diseases, Neuroimmune Interactions, its wide therapeutic aspects including the role of stem cells, Biomarkers, immune therapy along with psychiatric disorders which are most common outcomes of Neuroimmunological imbalance. Neuroimmunology-2019 summons participants from paramount universities, research institutions and diagnostic companies to exhibit their research expertise on all aspects of this rapidly expanding field.
In Asthma the pathological Roles of Neutrophil-Mediated Inflammation and its potential for Therapys a Target.
- It is caused by dysfunction of various types of cells, as well as cellular components, and is characterized by recruitment of inflammatory cells.
The focus on T- regulatory cells is in Immune checkpoint inhibitors in cancer therapy.
- Regulatory T cells (Tregs) play necessary roles in immune homeostasis; although, their role in tumor microenvironment (TME) is not entirely evident.
The antibodies of immunostimulatory monoclonal for hepatocellular carcinoma therapy. Trends and perspectives.
- In immunotherapy the success of immune checkpoint blockade has renewed interest in HCC.
The responses of kinetics and nadir to immune check point blockade by anti PD1 in patients with classical Hodgkin lymphoma.
- The aimed to define the depth and time of maximal anti-tumour response to programmed death-1 blockade antibodies (anti-PD1) in heavily pre-treated patients with classical Hodgkin lymphoma (HL).
The peptides conjugates of cell Adhesion for Therapeutics and Diagnostics against Autoimmune Diseases and cancer.
- Collectively, these studies display the potential of cell adhesion peptides in better the transportation of drug and diagnostic agents to diseased cells in clinical settings.